New hope for kids with tough cancers: daily pill combo aims to shrink tumors
NCT ID NCT02574728
Summary
This study is testing whether a combination of daily oral medications can shrink tumors in children whose cancers have come back or have not responded to standard treatments. The treatment involves taking several pills daily, including sirolimus, celecoxib, and alternating low doses of chemotherapy drugs. The main goal is to see if this approach can reduce tumor size and stop cancer growth in children with solid tumors or brain tumors.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Children's Healthcare of Atlanta, Scottish Rite
Atlanta, Georgia, 30342, United States
-
Children's Healthcare of Atlanta-Egleston
Atlanta, Georgia, 30322, United States
-
Children's Mercy Hospital
Kansas City, Missouri, 64108, United States
-
Nemours/Alfred I. duPont Hospital for Children
Wilmington, Delaware, 19803, United States
-
Phoenix Children's Hospital
Phoenix, Arizona, 85016, United States
-
University of Virginia Health System
Charlottesville, Virginia, 22908, United States
Conditions
Explore the condition pages connected to this study.